The Sle-Das Remission And Low Disease Activity States Discriminate Drug From Placebo And Better Health-Related Quality Of Life: Post-Hoc Analysis Of The Bliss-52 And Bliss-76 Phase Iii Trials.
AuthID
P-00X-E6S
P-00X-E6S